Researchers have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types — the most commonly used viral vectors for in vivo gene therapy. The researchers identified that GPR108, a G protein-coupled receptor, served as a molecular ‘lock’ to the cell. The discovery could one day enable scientists to better direct AAV gene transfers to specific tissues.
Click here for original story, Mechanism for how common gene therapy vectors enter cells
Source: ScienceDaily